Development of cardiometabolic risk factors following endocrine therapy in women with breast cancer.
Rillamas-Sun E, Kwan ML, Iribarren C, Cheng R, Neugebauer R, Rana JS, Nguyen-Huynh M, Shi Z, Laurent CA, Lee VS, Roh JM, Huang Y, Shen H, Hershman DL, Kushi LH, Greenlee H.
Rillamas-Sun E, et al. Among authors: greenlee h.
Breast Cancer Res Treat. 2023 Aug;201(1):117-126. doi: 10.1007/s10549-023-06997-x. Epub 2023 Jun 16.
Breast Cancer Res Treat. 2023.
PMID: 37326764
Free PMC article.